Literature DB >> 29740727

The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis.

Marc-Etienne Parent1, Maxime Richer2, Patrick Liang3.   

Abstract

To present an unrecognized vascular complication of bacillus Calmette-Guérin (BCG) therapy administered for superficial bladder carcinoma. We also review the potential mimickers for primary angiitis of the central nervous system (PACNS) as well as complications of intravesical BCG therapy. An 89-year-old Caucasian man with a history of relapsing high-grade bladder carcinoma treated with intravesical BCG presented with recurring episodes of right upper limb paresthesia with clumsiness and dysarthria. Magnetic resonance imaging of the head revealed multiple predominantly left-sided frontotemporal micronodular peri-vascular lesions. Left frontal lobe biopsy showed non-necrotizing granulomatous vasculitis. Ziehl staining was negative. Initially, he was treated for PACNS but his symptoms relapsed during every attempt to taper the corticosteroids. Six months later, he developed bilateral mycobacterial endophthalmitis, caused by Mycobacterium bovis. Brain biopsy was reviewed and confirmed the presence of perivascular mycobacteria. A retrospective diagnosis of BCG-induced central nervous system vasculitis was made and he was treated with high-dose corticosteroids, moxifloxacin, isoniazid, ethambutol, and rifampicin. BCG is a live attenuated form of Mycobacterium bovis widely used as tuberculosis vaccination and intravesical therapy for superficial forms of bladder cancer. Systemic complications affect roughly 5% of patients and can manifest months or years after the last instillation. Cases of endophthalmitis, meningitis, aortitis, or mycotic aneurysms have been described, but no reports of CNS vasculitis have been found. In disseminated forms of BCG infections, referred to as BCGitis, histopathology usually reveals granulomatous inflammation. Mycobacterial cultures are often negative, making this a diagnostic challenge. This is the first documented case of BCG-induced small-vessel CNS vasculitis. Mycobacterium bovis infection is rare and findings are often nonspecific, making the diagnosis very difficult. Other infectious and non-infectious causes must be ruled out appropriately before considering this entity.

Entities:  

Keywords:  Autoimmune diseases; Bacillus Calmette-Guérin; Immunology; Rheumatology; Vasculitis; Vasculitis mimickers

Mesh:

Substances:

Year:  2018        PMID: 29740727     DOI: 10.1007/s10067-018-4136-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  Brain biopsy in primary angiitis of the central nervous system.

Authors:  A Alrawi; J D Trobe; M Blaivas; D C Musch
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

2.  Meningovascular syphilis as a cause of basilar artery stenosis.

Authors:  A C Flint; B B Liberato; Y Anziska; J Schantz-Dunn; C B Wright
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

3.  Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.

Authors:  J A Martínez-Piñeiro; J Jiménez León; L Martínez-Piñeiro; L Fiter; J A Mosteiro; J Navarro; M J García Matres; P Cárcamo
Journal:  J Urol       Date:  1990-03       Impact factor: 7.450

4.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

Review 5.  Complications of intravesical therapy for urothelial cancer of the bladder.

Authors:  Madhusudan P Koya; Michael A Simon; Mark S Soloway
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

6.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

Review 7.  Diagnosis and classification of central nervous system vasculitis.

Authors:  Rula A Hajj-Ali; Leonard H Calabrese
Journal:  J Autoimmun       Date:  2014-02-01       Impact factor: 7.094

8.  Intravascular lymphoma mimicking cerebral stroke: report of two cases.

Authors:  Thomas Hundsberger; Sergio Cogliatti; Gian-Reto Kleger; Christian Fretz; Anita Gähler; Mark Anliker; Jean-Yves Fournier; Roger von Moos; Barbara Tettenborn; Christoph Driessen
Journal:  Case Rep Neurol       Date:  2011-10-24

9.  Three unusual mimics of primary angiitis of the central nervous system.

Authors:  Anupama Shahane; Atul Khasnis; Rula Hajj Ali
Journal:  Rheumatol Int       Date:  2010-12-16       Impact factor: 3.580

10.  Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.

Authors:  Ashish M Kamat; Joaquim Bellmunt; Matthew D Galsky; Badrinath R Konety; Donald L Lamm; David Langham; Cheryl T Lee; Matthew I Milowsky; Michael A O'Donnell; Peter H O'Donnell; Daniel P Petrylak; Padmanee Sharma; Eila C Skinner; Guru Sonpavde; John A Taylor; Prasanth Abraham; Jonathan E Rosenberg
Journal:  J Immunother Cancer       Date:  2017-08-15       Impact factor: 13.751

View more
  3 in total

Review 1.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

2.  A Case of Systemic Toxicity Related to Intravesical Bacillus Calmette-Guerin for the Treatment of Bladder Cancer.

Authors:  Sachin Gupta; Balraj Singh; Harshil Bhatt; Sandeep Singh; Sorab Gupta
Journal:  Cureus       Date:  2021-05-29

3.  Progressive Cerebral Small Vessel Disease Caused by an Autoimmune Response to Intravesical Bacille-Calmette-Guérin Treatment.

Authors:  Anouck Becker; Iris Quasar Grunwald; Marcus M Unger; Stefanie Behnke; Joerg Spiegel; Umut Yilmaz; Silke Walter; Klaus Faßbender
Journal:  Front Neurol       Date:  2020-10-26       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.